Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Neuronal acetylcholine receptor subunit alpha-7 | ||
Ligand | BDBM397138 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | FlexStation-Ca2+ Influx Assay | ||
EC50 | 300±n/a nM | ||
Citation | Maeng, CY; Jang, YK; Cha, SB; Shin, HW; Joung, CM; Yi, EJ Pharmaceutical composition comprising pyridone derivatives US Patent US9987259 Publication Date 6/5/2018 | ||
More Info.: | Get all data from this article, Assay Method | ||
Neuronal acetylcholine receptor subunit alpha-7 | |||
Name: | Neuronal acetylcholine receptor subunit alpha-7 | ||
Synonyms: | ACHA7_HUMAN | CHRNA7 | Cholinergic, Nicotinic Alpha7 | NACHRA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | Neuronal acetylcholine receptor subunit alpha-7 (nAChR-alpha 7) | Nicotinic acetylcholine receptor alpha-7 (alpha7 nAChR) | ||
Type: | n/a | ||
Mol. Mass.: | 56448.33 | ||
Organism: | Homo sapiens (Human) | ||
Description: | CHRNA7 (NACHRA7) | ||
Residue: | 502 | ||
Sequence: |
| ||
BDBM397138 | |||
n/a | |||
Name | BDBM397138 | ||
Synonyms: | N-(1-azabicyclo[2.2.2]octan-3-yl)-1-(1,3-benzothiazole-2-yl)-6-oxo-3-pyridinecarboxamide | US10456385, Example 33 | US9987259, Example 33 | ||
Type | Small organic molecule | ||
Emp. Form. | C20H20N4O2S | ||
Mol. Mass. | 380.463 | ||
SMILES | O=C(NC1CN2CCC1CC2)c1ccc(=O)n(c1)-c1nc2ccccc2s1 |(2.37,1.49,;2.37,-.05,;3.71,-.82,;5.04,-.05,;5.04,1.49,;6.37,2.26,;7.71,1.49,;7.71,-.05,;6.37,-.82,;7.14,.51,;5.6,.92,;1.04,-.82,;1.04,-2.36,;-.29,-3.13,;-1.63,-2.36,;-2.96,-3.13,;-1.63,-.82,;-.29,-.05,;-2.96,-.05,;-3.12,1.48,;-4.63,1.8,;-5.4,3.13,;-6.94,3.13,;-7.71,1.8,;-6.94,.47,;-5.4,.47,;-4.37,-.68,)| | ||
Structure |